All In Biotech

Drug Trial Radar · NCT07444567

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

ROSY-F: Roll-Over Study for Participants Who Have Completed a Previous Study With Benralizumab (Fasenra) and Are Judged by the Investigator to Clinically Benefit From Continued Treatment

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

230

Planned (sponsor's estimate)

Start

Jul 24, 2026

Primary completion

Dec 27, 2029

Study completion Dec 27, 2029

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Mar 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The rationale of the roll-over study (ROSY) is to provide continuous access to study treatment for participants who have completed or exited a parent study and are deemed appropriate for continued benralizumab treatment, as judged by the Investigator, while monitoring long-term safety and tolerability of benralizumab.

Conditions

  • Asthma
  • Eosinophilic Granulomatosis With Polyangiitis (EGPA)
  • Hypereosinophilic Syndrome (HES)

Interventions

  • BenralizumabDrug

    Accessorized Pre-Filled Syringe (Solution for injection).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety will be evaluated by monitoring and assessing SAEs and non-serious AEs reported throughout the study and until 8 weeks after the last dose of benralizumabTime frame: From baseline until 8 weeks after the last dose of benralizumab

Locations

46 sites in 14 countries. Site status is shown where the registry gives one.

  • Research Site

    Aurora, Colorado · Not yet recruiting

  • Research Site

    Bethesda, Maryland · Not yet recruiting

  • Research Site

    Ann Arbor, Michigan · Not yet recruiting

  • Research Site

    Northfield, New Jersey · Not yet recruiting

  • Research Site

    The Bronx, New York · Not yet recruiting

  • Research Site

    Durham, North Carolina · Not yet recruiting

  • Research Site

    Cleveland, Ohio · Recruiting

  • Research Site

    Salt Lake City, Utah · Not yet recruiting

  • Research Site

    Buenos Aires, Argentina · Recruiting

  • Research Site

    Florida, Argentina · Recruiting

  • Research Site

    Lobos, Argentina · Not yet recruiting

  • Research Site

    Mar del Plata, Argentina · Recruiting

  • Research Site

    Mendoza, Argentina · Recruiting

  • Research Site

    Mendoza, Argentina · Recruiting

  • Research Site

    Rosario, Argentina · Recruiting

  • Research Site

    San Juan Bautista, Argentina · Not yet recruiting

  • Research Site

    Innsbruck, Austria · Not yet recruiting

  • Research Site

    Brussels, Belgium · Recruiting

  • Research Site

    Edegem, Belgium · Not yet recruiting

  • Research Site

    Calgary, Alberta, Canada · Not yet recruiting

  • Research Site

    Hamilton, Ontario, Canada · Recruiting

  • Research Site

    Toronto, Ontario, Canada · Recruiting

  • Research Site

    Toronto, Ontario, Canada · Not yet recruiting

  • Research Site

    Toronto, Ontario, Canada · Recruiting

  • Research Site

    Bron, France · Not yet recruiting

  • Research Site

    Marseille, France · Recruiting

  • Research Site

    Montpellier, France · Recruiting

  • Research Site

    Nantes, France · Recruiting

  • Research Site

    Paris, France · Recruiting

  • Research Site

    Paris, France · Recruiting

  • Research Site

    Pessac, France · Recruiting

  • Research Site

    Suresnes, France · Recruiting

  • Research Site

    Ahmedabad, India · Withdrawn

  • Research Site

    Ajmer, India · Not yet recruiting

  • Research Site

    Haifa, Israel · Recruiting

  • Research Site

    Holon, Israel · Recruiting

  • Research Site

    Petah Tikva, Israel · Not yet recruiting

  • Research Site

    Roma, Italy · Withdrawn

  • Research Site

    Rotterdam, Netherlands · Not yet recruiting

  • Research Site

    Chęciny, Poland · Not yet recruiting

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.